This report studies the global Obesity Market status and forecast, categorizes the global Obesity Market
size (value & volume), revenue (Million USD), product price by manufacturers, type, application, and
region. Medical Obesity Market Report by Material, Application, and Geography-Global Forecast to 2028
is an expert and far-reaching research provide details regarding the world’s major provincial economic
situations, concentrating on the principle districts.
Obesity is a preventable chronic condition characterised by raised body mass index (BMI ≥30), which
contributes to the pathogenesis of cardiovascular diseases, type 2 diabetes (T2D), musculoskeletal
disorders, and several major cancers. Obesity has become an epidemic and it is recognised as one of the
major health issues due to its associated high rates of morbidity, mortality, and health cost.
Some of the diseases to which an obese individual is prone include type II diabetes, heart diseases,
osteoarthritis and even certain types of cancer. One-third of adults in the U.S are obese. The rising pace
of obesity and chronic diseases is creating the need for weight loss programs and obesity management.
Major Players profiled in the Obesity Market report incorporate: VIVUS, Inc., Arena Pharmaceuticals,
Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Allergan Plc, Medtronic, Ethicon (subsidiary of
Johnson & Johnson), Cousin Biotech, EnteroMedics
Industry News:
Allergan plc (NYSE: AGN) today announced that the CoolSculpting® treatment received FDA clearance to
treat the submandibular area. In addition, the FDA clearance was expanded to include patients with a
BMI of up to 46.2 when treating the submental and submandibular areas. This recent clearance makes
CoolSculpting® the first and only nonsurgical fat reduction treatment to contour the area below the
jawline and improve the appearance of lax tissue in conjunction with submental fat treatments.
The efficacy of the CoolSculpting® treatment in the area right below the jawline was proven in a 22-
week clinical study, which demonstrated an average 33 percent reduction in fat layer thickness after two
treatments.2 Additionally, an average 85 percent patient satisfaction rate was reported across three
studies.
Purchase this report online with 80 Pages, List of Tables & Figures and in-depth Table of Contents on
“Global Obesity Market Report 2019” @ https://www.businessindustryreports.com/buy-
now/164620/single .
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Obesity in these regions, from 2014 to 2028 (forecast), covering: North
America, Europe, Asia Pacific, Middle East & Africa and South America.
Report contents include
1 Analysis of Obesity Market including revenues, future growth, market outlook
2 Historical data and forecast